Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pan-Chyr Yang

Showing results (281-290 of 495) with videos related to

Pageof 50
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 30, 2011
EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with wild-type EGFRShang-Gin Wu, Yao-Wen Kuo, Yih-Leong Chang, et al.
EMBO Molecular Medicine|March 16, 2012
TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinomaJau-Chen Lin, Yi-Ying Wu, Jing-Yi Wu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 29, 2012
Viral load and clinical features in children infected with seasonal influenza B in 2006/2007Tsung-Pei Tsou, Pei-Lan Shao, Chun-Yi Lu, et al.
Cancer Research|May 16, 2019
Cancer-Associated Fibroblasts Produce Netrin-1 to Control Cancer Cell PlasticityPei-Ju Sung, Nicolas Rama, Jeromine Imbach, et al.
Analytica Chimica Acta|March 26, 2021
Integrating site-specific peptide reporters and targeted mass spectrometry enables rapid substrate-specific kinase assay at the nanogram cell levelAaron James F Reyes, Reta Birhanu Kitata, Mira Anne C Dela Rosa, et al.
Oncotarget|February 11, 2016
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patientsShang-Gin Wu, Yi-Nan Liu, Meng-Feng Tsai, et al.
Bioorganic & Medicinal Chemistry|March 11, 2015
Novel curcumin analogs to overcome EGFR-TKI lung adenocarcinoma drug resistance and reduce EGFR-TKI-induced GI adverse effectsKoji Wada, Jen-Yi Lee, Hsin-Yi Hung, et al.
Biochemical and Biophysical Research Communications|July 23, 2005
EMP-1 is a junctional protein in a liver stem cell line and in the liverHsuan-Shu Lee, James L Sherley, Jeremy J W Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2022
Cox Proportional Hazard Ratios Overestimate Survival Benefit of Immune Checkpoint Inhibitors: Cox-TEL Adjustment and Meta-Analyses of Programmed Death-Ligand 1 Expression and Immune Checkpoint Inhibitor Survival BenefitEmily Pei-Ying Lin, Chih-Yuan Hsu, Jeng-Fong Chiou, et al.
Oncotarget|October 6, 2017
Astrocyte-elevated gene-1 confers resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase expressionChung-Yu Chen, Ying-Yin Chen, Jeremy J W Chen, et al.
Pageof 50

Showing results (281-290 of 495) with videos related to

Sort By:
Pageof 50
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 30, 2011
EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with wild-type EGFRShang-Gin Wu, Yao-Wen Kuo, Yih-Leong Chang, et al.
EMBO Molecular Medicine|March 16, 2012
TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinomaJau-Chen Lin, Yi-Ying Wu, Jing-Yi Wu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 29, 2012
Viral load and clinical features in children infected with seasonal influenza B in 2006/2007Tsung-Pei Tsou, Pei-Lan Shao, Chun-Yi Lu, et al.
Cancer Research|May 16, 2019
Cancer-Associated Fibroblasts Produce Netrin-1 to Control Cancer Cell PlasticityPei-Ju Sung, Nicolas Rama, Jeromine Imbach, et al.
Analytica Chimica Acta|March 26, 2021
Integrating site-specific peptide reporters and targeted mass spectrometry enables rapid substrate-specific kinase assay at the nanogram cell levelAaron James F Reyes, Reta Birhanu Kitata, Mira Anne C Dela Rosa, et al.
Oncotarget|February 11, 2016
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patientsShang-Gin Wu, Yi-Nan Liu, Meng-Feng Tsai, et al.
Bioorganic & Medicinal Chemistry|March 11, 2015
Novel curcumin analogs to overcome EGFR-TKI lung adenocarcinoma drug resistance and reduce EGFR-TKI-induced GI adverse effectsKoji Wada, Jen-Yi Lee, Hsin-Yi Hung, et al.
Biochemical and Biophysical Research Communications|July 23, 2005
EMP-1 is a junctional protein in a liver stem cell line and in the liverHsuan-Shu Lee, James L Sherley, Jeremy J W Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2022
Cox Proportional Hazard Ratios Overestimate Survival Benefit of Immune Checkpoint Inhibitors: Cox-TEL Adjustment and Meta-Analyses of Programmed Death-Ligand 1 Expression and Immune Checkpoint Inhibitor Survival BenefitEmily Pei-Ying Lin, Chih-Yuan Hsu, Jeng-Fong Chiou, et al.
Oncotarget|October 6, 2017
Astrocyte-elevated gene-1 confers resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase expressionChung-Yu Chen, Ying-Yin Chen, Jeremy J W Chen, et al.
Pageof 50